Aurinia Pharmaceuticals Inc.
AUPH
Revenue
77.11M
▲3.65M▲4.96%
3 Months ChangeAssets
326.68M
▲180.82M▲123.97%
12 Months ChangeLiabilities
53.17M
▲19.88M▲59.72%
12 Months ChangeFree Cash Flow
-63.54M
▼-11.90M▼-23.05%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001600620-26-000015
2025-11-04
Form 8-K
ID: 0001600620-25-000108
2025-11-04
Form 10-Q
ID: 0001600620-25-000106
2025-07-31
Form 10-Q
ID: 0001600620-25-000092
2025-07-31
Form 8-K
ID: 0001600620-25-000090
2025-06-30
Form 8-K
ID: 0001600620-25-000083
2025-05-15
Form 8-K
ID: 0001600620-25-000057
2025-05-12
Form 10-Q
ID: 0001600620-25-000049
2025-05-12
Form 8-K
ID: 0001600620-25-000047
2025-02-27
Form 8-K
ID: 0001600620-25-000009